Plasma Protein Therapeutics Association
- Assets
- $7.8m
- Revenue
- $13.0m
- Investments
- $0.0
- Employees
- 28
- Location
- Annapolis, MD
- Founding
- 12/1993
- Data as of
- 12/2021
- EIN
- 52-1800187
Organization Overview
Plasma Protein Therapeutics Association, operating under the name Ppta, is located in Annapolis, MD. The organization was established in 1993. According to its NTEE Classification (E03) the organization is classified as: Professional Societies & Associations, under the broad grouping of Health Care and related organizations. As of 12/2021, Ppta employed 28 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ppta is a 501(c)(6) and as such, is described as a "Business League, Chambers of Commerce, or Real Estate Board" by the IRS.
For the year ending 12/2021, Ppta generated $13.0m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 1.9% each year. All expenses for the organization totaled $14.5m during the year ending 12/2021. While expenses have increased by 5.4% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
PPTA ADVOCATES AND PROMOTES SAFE AND EFFECTIVE PLASMA PROTEIN THERAPEUTICS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PPTA REPRESENTS THE INTERESTS OF THE PLASMA COLLECTION AND FRACTIONATION INDUSTRY WITH REGARD TO REGULATORY, LEGISLATIVE AND OTHER PUBLIC POLICY ISSUES. PPTA STAFF WORKS COOPERATIVELY WITH GOVERNMENTAL INSTITUTIONS AND REGULATORY AGENCIES THROUGHOUT THE WORLD. PPTA STAFF MONITOR REGULATORY AND POLICY ACTIVITIES (UNITED STATES CONGRESS, THE EUROPEAN COMMISSION, THE WORLD HEALTH ORGANIZATION, FDA, EMEA AND VARIOUS OTHER INTERNATIONAL AND NATIONAL REGULATORY AGENCIES AND COMMITTEES), COORDINATE INDUSTRY POSITIONS ON EXISTING, NEW AND EMERGING ISSUES, AND DEFINE AND DEVELOP STRATEGIC INITIATIVES THAT ENHANCE THE INDUSTRY'S REGULATORY ENVIRONMENT. PPTA SPEAKS WITH ONE VOICE ON ASSOCIATION AND MEMBER PROGRAMS. FOUNDED IN 1994, PPTA EUROPE, FORMERLY THE EUROPEAN ASSOCIATION OF THE PLASMA PRODUCTS INDUSTRY (EAPPI), IS THE PRIMARY ADVOCATE FOR THE LEADING PRODUCERS OF PLASMA-BASED AND RELATED RECOMBINANT BIOLOGICAL THERAPEUTICS. THE ASSOCIATION, THROUGH ITS WORKING GROUPS, DEVELOPS INDUSTRY-WIDE CONSENSUS POSITIONS AND INITIATIVES. PPTA EUROPE ACTS AS THE PRINCIPAL INTERLOCUTOR WITH REGULATORY AUTHORITIESON A NATIONAL AND EUROPEAN LEVEL AND WITH NATIONAL GOVERNMENTS. PPTA EUROPE IS COMMITTED TO BEING INVOLVED IN ALL DISCUSSIONS DIRECTLY RELEVANT TO THE PLASMA THERAPEUTICS INDUSTRY AND THE PATIENTS WHO DEPEND ON THE MEDICINES PRODUCED BY OUR MEMBERS. PATIENT NOTIFICATION SYSTEM: THE PATIENT NOTIFICATION SYSTEM IS A FREE, CONFIDENTIAL, 24-HOUR COMMUNICATION SYSTEM PROVIDING INFORMATION ON PLASMA-DERIVED AND RECOMBINANT PRODUCT WITHDRAWALS AND RECALLS IN NORTH AMERICA. THE SYSTEM WAS CREATED TO PROVIDE CONSUMERS WITH A SINGLE, CONVENIENT AND CONFIDENTIAL SOURCE FOR UP-TO-DATE PRODUCT WITHDRAWAL AND RECALL INFORMATION. LED BY THE PLASMA PROTEIN THERAPEUTICS ASSOCIATION (PPTA), THE PATIENT NOTIFICATION SYSTEM WAS DEVELOPED BY THE PRODUCERS AND DISTRIBUTORS OF PLASMA PRODUCTS WITH DIRECT INPUT FROM CONSUMERS. ORIGINALLY AVAILABLE IN THE US, IN 2002, THE SYSTEM EXTENDED TO PPTA REPRESENTS THE INTERESTS OF THE PLASMA COLLECTION AND FRACTIONATION INDUSTRY WITH REGARD TO REGULATORY, LEGISLATIVE AND OTHER PUBLIC POLICY ISSUES. PPTA STAFF WORKS COOPERATIVELY WITH GOVERNMENTAL INSTITUTIONS AND REGULATORY AGENCIES THROUGHOUT THE WORLD. PPTA STAFF MONITOR REGULATORY AND POLICY ACTIVITIES (UNITED STATES CONGRESS, THE EUROPEAN COMMISSION, THE WORLD HEALTH ORGANIZATION, FDA, EMEA AND VARIOUS OTHER INTERNATIONAL AND NATIONAL REGULATORY AGENCIES AND COMMITTEES), COORDINATE INDUSTRY POSITIONS ON EXISTING, NEW AND EMERGING ISSUES, AND DEFINE AND DEVELOP STRATEGIC INITIATIVES THAT ENHANCE THE INDUSTRY'S REGULATORY ENVIRONMENT. PPTA SPEAKS WITH ONE VOICE ON ASSOCIATION AND MEMBER PROGRAMS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Amy Efantis President & | Officer | 40 | $628,125 |
Julie Birkofer Sr VP Public | Officer | 40 | $420,188 |
Joshua Penrod Sr VP Int'l | Officer | 40 | $348,620 |
John Delacourt VP Global In | Officer | 40 | $342,200 |
Mary Gustafson VP Regulator | Officer | 40 | $338,568 |
Larisa Cervenakova Medical Dire | 40 | $259,168 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $13,000,457 |
| Investment income | $1,942 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $13,003,501 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,435,908 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $2,520,201 |
| Pension plan accruals and contributions | $275,000 |
| Other employee benefits | $650,036 |
| Payroll taxes | $274,826 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $237,181 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $786,742 |
| Advertising and promotion | $0 |
| Office expenses | $15,521 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $261,051 |
| Travel | $7,364 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $190 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $33,255 |
| All other expenses | $622,260 |
| Total functional expenses | $14,517,854 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $4,520,089 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $941,359 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $64,467 |
| Net Land, buildings, and equipment | $805,845 |
| Investments—publicly traded securities | $1,496,484 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $7,828,244 |
| Accounts payable and accrued expenses | $1,731,546 |
| Grants payable | $0 |
| Deferred revenue | $709,439 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $31,225 |
| Total liabilities | $2,472,210 |
| Net assets without donor restrictions | $5,356,034 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $7,828,244 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
American Health Care Association And Subsidiary Washington, DC | $42,939,988 | $48,686,518 |
American Physical Therapy Association Alexandria, VA | $61,402,503 | $48,378,744 |
American College Of Obstetricians And Gynecologists Washington, DC | $106,112,762 | $64,499,818 |
American Pharmacists Association Washington, DC | $163,886,868 | $44,521,432 |
American Nurses Association Inc Silver Spring, MD | $72,047,526 | $33,274,226 |
National Association Of Childrens Hospital And Related Institutions Washington, DC | $129,313,033 | $43,392,577 |
Oncology Nursing Society Pittsburgh, PA | $48,820,451 | $29,142,020 |
American Society Of Nephrology Inc Washington, DC | $85,761,942 | $25,981,219 |
American Academy Of Physician Assistants Inc Alexandria, VA | $37,287,618 | $27,625,692 |
American College Of Cardiology Washington DC, DC | $26,183,566 | $22,719,539 |
Inteleos Inc Rockville, MD | $32,845,295 | $22,272,496 |
Chop Clinical Associates Inc Philadelphia, PA | $1,382,809 | $20,179,810 |